Ra Capital Management, L.P. Alpine Immune Sciences, Inc. Transaction History

Ra Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$8.54 - $20.22 $41.9 Million - $99.3 Million	4,909,763 New	4,909,763 $93.6 Million
Q2 2023 Aug 14, 2023	BUY	$6.84 - $11.91 $20,950 - $36,480	3,063 Added 0.07%	4,691,178 $48.2 Million
Q1 2023 May 15, 2023	BUY	$7.0 - $8.75 $2.04 Million - $2.54 Million	290,747 Added 6.61%	4,688,115 $36.2 Million
Q4 2022 Feb 14, 2023	BUY	$5.45 - $7.35 $222,011 - $299,409	40,736 Added 0.94%	4,397,368 $32.3 Million
Q3 2022 Nov 14, 2022	BUY	$6.89 - $9.39 $30 Million - $40.9 Million	4,356,632 New	4,356,632 $31.4 Million

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.